The blood pressure drugs enalapril and losartan, which researchers hoped would also slow down the loss of kidney function in Type 1 diabetics, have failed to achieve that goal. However, in a recent study, the drugs had the unintended benefit of reducing eye damage by 65% to 70%. Read the full article here: http://diabetesnewshound.com/?p=324
